[Pharmacotherapy of patients with (early) rheumatoid arthritis].
van Rijthoven
A W
AW
D000380:Agranulocytosis / Q000517:prevention & control; D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D012460:Sulfasalazine / Q000008:administration & dosage / Q000009:adverse effects
D018501:Antirheumatic Agents; D012460:Sulfasalazine; D016572:Cyclosporine; D008727:Methotrexate